pyrogallol has been researched along with Parkinson Disease, Secondary in 1 studies
benzenetriol : A triol in which three hydroxy groups are substituted onto a benzene ring.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbeau, A | 1 |
| Dallaire, L | 1 |
| Buu, NT | 1 |
| Veilleux, F | 1 |
| Boyer, H | 1 |
| de Lanney, LE | 1 |
| Irwin, I | 1 |
| Langston, EB | 1 |
| Langston, JW | 1 |
1 other study available for pyrogallol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Brain Chemistry; | 1985 |